Seres Therapeutics Inc
Change company Symbol lookup
Select an option...
MCRB Seres Therapeutics Inc
TC TuanChe Ltd
ENSG Ensign Group Inc
INO Inovio Pharmaceuticals Inc
WHR Whirlpool Corp
TTOO T2 Biosystems Inc
AAPL Apple Inc
HOKCY Hong Kong and China Gas Co Ltd
NWFFX American Funds New World Fund® Class F-1
CARS Cars.com Inc
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Seres Therapeutics, Inc. is a microbiome therapeutics platform company. The Company is engaged in developing a class of biological drugs, which is referred as Ecobiotic microbiome therapeutics. The Company's drugs are designed to restore health by repairing the function of a dysbiotic microbiome. The Company is focused on implementing its microbiome therapeutics platform to develop Ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. SER-109 is its lead product candidate, which is designed to prevent further recurrences of Clostridium difficile infection (CDI). The Company is developing additional product candidates, including SER-262 to prevent an initial recurrence of primary CDI; SER-287 and SER-301, to treat inflammatory bowel disease (IBD), including ulcerative colitis, and SER-155 to treat enteric bacterial pathogens.

Closing Price
$25.65
Day's Change
-1.21 (-4.50%)
Bid
--
Ask
--
B/A Size
--
Day's High
26.24
Day's Low
24.26
Volume
(Heavy Day)
Volume:
2,265,886

10-day average volume:
883,858
2,265,886

Unable to locate that news article. Back to news results

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.